Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (43)

2020

  1. Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression

    British Journal of Haematology, Vol. 189, Núm. 6, pp. 1064-1073

2016

  1. Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity

    Immunologic Research, Vol. 64, Núm. 2, pp. 548-557

2013

  1. Hepatoblastoma en el adulto

    Revista Espanola de Enfermedades Digestivas, Vol. 105, Núm. 4, pp. 229-231

2011

  1. Altered transcription factor E3 expression in unclassified adult renal cell carcinoma indicates adverse pathological features and poor outcome

    BJU International, Vol. 108, Núm. 2 B

  2. Association of steroid and xenobiotic receptor (SXR) and multidrug resistance 1 (MDR1) gene expression with survival among patients with invasive bladder carcinoma

    BJU International, Vol. 107, Núm. 11, pp. 1833-1838

  3. Prostatic leiomyoma. Case report

    Archivos Espanoles de Urologia, Vol. 64, Núm. 7, pp. 631-635

2009

  1. Clasificación y diagnóstico anatomopatológico de los tumores hepáticos benignos

    Gastroenterologia y Hepatologia Continuada, Vol. 8, Núm. 1, pp. 1-8

  2. Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array

    British Journal of Cancer, Vol. 101, Núm. 11, pp. 1876-1883

  3. Large cell carcinoma of the lung: An endangered species?

    Applied Immunohistochemistry and Molecular Morphology, Vol. 17, Núm. 5, pp. 383-392

2007

  1. Fourth branchial cyst within the thyrohyoid membrane: a difficult differential diagnosis with mixed laryngocele

    Revista de medicina de la Universidad de Navarra, Vol. 51, Núm. 4, pp. 34-37

  2. Pseudomesotheliomatous carcinoma of the lung with a distinct morphology, immunohistochemistry, and comparative genomic hybridization profile

    Annals of Diagnostic Pathology, Vol. 11, Núm. 4, pp. 241-251

2006

  1. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma

    International Journal of Radiation Oncology Biology Physics, Vol. 66, Núm. 3, pp. 792-800

2005

  1. Mutation analysis of the SDHD gene in four kindreds with familial paraganglioma

    Diagnostic Molecular Pathology, Vol. 14, Núm. 2, pp. 109-114

2004

  1. Central retinal vascular occlusion by orbital pseudotumor

    Retina, Vol. 24, Núm. 3, pp. 455-458

  2. Imatinib Inhibits Proliferation of Ewing Tumor Cells Mediated by the Stem Cell Factor/KIT Receptor Pathway, and Sensitizes Cells to Vincristine and Doxorubicin-Induced Apoptosis

    Clinical Cancer Research, Vol. 10, Núm. 2, pp. 751-761

2003

  1. Angiomyolipoma and PEComa are immunoreactive for MyoD1 in cell cytoplasmic staining pattern

    Applied Immunohistochemistry and Molecular Morphology, Vol. 11, Núm. 2, pp. 156-160

  2. Molecular biology of follicular thyroid carcinoma (II). Clinical applications.

    Revista de medicina de la Universidad de Navarra, Vol. 47, Núm. 2, pp. 23-29

  3. PTEN protein expression correlates with PTEN gene molecular changes but not with VEGF expression in astrocytomas

    Diagnostic Molecular Pathology, Vol. 12, Núm. 3, pp. 160-165

2000

  1. Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma

    American Journal of Pathology, Vol. 156, Núm. 3, pp. 849-855

  2. Clinico-pathologic, immunohistochemical, and TUNEL study in early cardiac allograft failure

    Cardiovascular Pathology, Vol. 9, Núm. 3, pp. 153-159